BioCentury
ARTICLE | Company News

Anti-cancer collaboration

February 23, 2000 8:00 AM UTC

Kinetix (Medford, Mass.) and the Dana-Farber Cancer Institute will evaluate the potential of small molecules to treat prostate cancer by inhibiting Akt, a cellular enzyme that regulates apoptosis. Kin...